Skip to main content
. 2011 Aug 23;105(7):1002–1011. doi: 10.1038/bjc.2011.303

Figure 3.

Figure 3

The truncated form of CD9P-1, GS-168AT2, inhibits dose-dependently in vitro angiogenesis. (A) Representative images showing that GS-168AT2 inhibits in vitro angiogenesis in a concentration-dependent manner, and (B) its quantification. Results were expressed as mean±s.e. (n=4).